3-methyl-2-[(5E)-5-[(E)-2-methyl-3-phenylprop-2-enylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]butanoic acid

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 3-methyl-2-[(5E)-5-[(E)-2-methyl-3-phenylprop-2-enylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]butanoic acid
• 化学式: C₁₈H₁₉NO₃S₂
• 分子量: 361.5
• InChiKey: WZSFHXDLBDYXPF-USTLKGCXSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.2
• 重原子数：
  24
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.28
• 拓扑面积：
  115
• 氢给体数：
  1
• 氢受体数：
  5

文献信息

• Inhibitor of Anti-Apoptotic Proteins
  申请人：Pellecchia Maurizio

  公开号：US20090258914A1

  公开（公告）日：2009-10-15

  A compound having the structure A is described as well as the use of such compounds to inhibit at least one BCL-2 protein family member.

  描述了一种具有结构A的化合物，以及使用这种化合物来抑制至少一种BCL-2蛋白家族成员的方法。
• Chemical entities that kill senescent cells for use in treating age-related disease
  申请人：Unity Biotechnology, Inc.

  公开号：US10195213B2

  公开（公告）日：2019-02-05

  Disclosed herein are compounds that are effective for treatment of various disease states associated with senescence. The disclosed compounds can be used to eliminate senescent cells for disease treatment. The dosing of the compounds includes both single administration and regimens of cycling dosages.

  本文公开的化合物可有效治疗与衰老有关的各种疾病状态。所公开的化合物可用于消除衰老细胞以治疗疾病。化合物的给药方式包括单次给药和循环给药。
• DI-SUBSTITUTED AMIDES FOR ENHANCING GLUTAMATERGIC SYNAPTIC RESPONSES
  申请人：CORTEX PHARMACEUTICALS, INC.

  公开号：EP2154970A1

  公开（公告）日：2010-02-24
• INHIBITORS OF ANTI-APOPTOTIC PROTEINS
  申请人：Burnham Institute for Medical Research

  公开号：EP2214674A1

  公开（公告）日：2010-08-11
• COMPOUNDS AND THERAPEUTIC USES
  申请人：Unity Biotechnology, Inc.

  公开号：US20170281649A1

  公开（公告）日：2017-10-05

  Disclosed herein are compounds that are effective for treatment of various disease states associated with senescence. The disclosed compounds can be used to eliminate senescent cells for disease treatment. The dosing of the compounds includes both single administration and regimens of cycling dosages.